CAPTURING PHASE 1 VARIABILITY WITH INDIVIDUALIZED QSP VIRTUAL PATIENTS TO SUPPORT CLINICAL DOSE RESPONSE CHARACTERIZATION FOR CD20/CD3 BISPECIFIC ANTIBODY MOSUNETUZUMAB.
CLINICAL PHARMACOLOGY & THERAPEUTICS（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined